Calisher CH, Calzolari M. Taxonomy of phleboviruses, emphasizing those that are sandfly-borne. Viruses. 2021;13(5):918.
Article CAS PubMed PubMed Central Google Scholar
Anywaine Z, Lule SA, Hansen C, Warimwe G, Elliott A. Clinical manifestations of Rift Valley fever in humans: systematic review and meta-analysis. PLoS Negl Trop Dis. 2022;16(3):e0010233.
Article CAS PubMed PubMed Central Google Scholar
Schwentker FF, Rivers TM. Rift Valley fever in man: report of a fatal laboratory infection complicated by thrombophlebitis. J Exp Med. 1934;59(3):305–13.
Article CAS PubMed PubMed Central Google Scholar
Nanyingi MO, Munyua P, Kiama SG, Muchemi GM, Thumbi SM, Bitek AO, Bett B, Muriithi RM, Njenga MK. A systematic review of Rift Valley Fever epidemiology 1931–2014. Infection ecology & epidemiology 2015, 5(1):28024.
Smithburn K, Haddow A, Gillett J. Rift Valley fever. Isolation of the virus from wild mosquitoes. Br J Exp Pathol. 1948;29(2):107.
CAS PubMed PubMed Central Google Scholar
Henderson BEM, McCrae AWR, Kirya BG, Ssenkubuge Y, Sempala SDK. Arbovirus epizootics involving man, mosquitoes and vertebrates at Lunyo, Uganda 1968. Ann Trop Med Parasitol. 1972;66(3):343–55.
Article CAS PubMed Google Scholar
Shoemaker TR, Nyakarahuka L, Balinandi S, Ojwang J, Tumusiime A, Mulei S, Kyondo J, Lubwama B, Sekamatte M, Namutebi A. First laboratory-confirmed outbreak of human and animal Rift Valley fever virus in Uganda in 48 years. Am J Trop Med Hyg. 2019;100(3):659.
Article PubMed PubMed Central Google Scholar
Nyakarahuka L, Whitmer S, Klena J, Balinandi S, Talundzic E, Tumusiime A, Kyondo J, Mulei S, Patel K, Baluku J. Detection of Sporadic Outbreaks of Rift Valley Fever in Uganda through the national viral hemorrhagic fever Surveillance System, 2017–2020. The American journal of tropical medicine and hygiene 2023:tpmd220410.
Birungi D, Aceng FL, Bulage L, Nkonwa IH, Mirembe BB, Biribawa C, Okethwangu D, Opio ND, Monje F, Muwanguzi D. Sporadic Rift Valley Fever Outbreaks in Humans and Animals in Uganda, October 2017–January 2018. Journal of Environmental and Public Health 2021, 2021.
Uganda MoH: National Technical Guidelines for Integrated Disease Surveillance and Response. Third edition. September 2021. Last accessed 09 January 2023; URL: https://www.afro.who.int/sites/default/files/2021-09/2_Uganda%203rd%20IDSR%20Tech%20Guideline_PrintVersion_10Sep2021.pdf. 2021(Third edition).
Javelle E, Lesueur A, de Santi VP, de Laval F, Lefebvre T, Holweck G, Durand GA, Leparc-Goffart I, Texier G, Simon F. The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal. Ann Clin Microbiol Antimicrob. 2020;19(1):4.
Article PubMed PubMed Central Google Scholar
Ksiazek T, Rollin P, Williams A, Bressler D, Martin M, Swanepoel R, Burt F, Leman P, Khan A, Rowe A. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Supplement1):S177–87.
Bird BH, Bawiec DA, Ksiazek TG, Shoemaker TR, Nichol ST. Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J Clin Microbiol. 2007;45(11):3506–13.
Article CAS PubMed PubMed Central Google Scholar
Baba M, Masiga DK, Sang R, Villinger J. Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa? Emerg Microbes Infections. 2016;5(6):e58.
Boushab BM, Fall-Malick FZ, Ould Baba SEW, Ould Salem ML, Belizaire MRD, Ledib H, Ould Baba Ahmed MM, Basco LK, Ba H. Severe human illness caused by Rift Valley Fever Virus in Mauritania, 2015. Open Forum Infect Dis. 2016;3(4):ofw200–200.
Article PubMed PubMed Central Google Scholar
Cêtre-Sossah C, Pédarrieu A, Juremalm M, Van Jansen P, Brun A, Ould EL, Mamy AB, Héraud J-M, Filippone C, Ravalohery J-P, Chaabihi H. Development and validation of a pen side test for Rift Valley fever. PLoS Negl Trop Dis. 2019;13(9):e0007700.
Article PubMed PubMed Central Google Scholar
Al-Hazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Bushra A, Hazmi A, Abdullah M, Abbo H, Elamin A. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin Infect Dis. 2003;36(3):245–52.
Adam AA, Karsany MS, Adam I. Manifestations of severe Rift Valley fever in Sudan: International Journal of Infectious Diseases; 2010. 14(2):e179-e180.; 2010.
Rakotoarivelo R, Andrianasolo R, Razafimahefa S, Randremandranto RNS, Randria M. Severe presentations of Rift Valley fever in Madagascar. Méd Mal Infect. 2011;41(6):318–21.
Article CAS PubMed Google Scholar
Nguku PM, Sharif S, Mutonga D, Amwayi S, Omolo J, Mohammed O, Farnon EC, Gould LH, Lederman E, Rao C. An investigation of a major outbreak of Rift Valley fever in Kenya: 2006–2007. Am J Trop Med Hyg. 2010;83(2Suppl):05–13.
Article PubMed Central Google Scholar
Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck‐Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. 2015;14(3):309–21.
Article PubMed PubMed Central Google Scholar
Mohamed M, Mosha F, Mghamba J, Zaki SR, Shieh WJ, Paweska J, Omulo S, Gikundi S, Mmbuji P, Bloland P, Zeidner N, Kalinga R, Breiman RF, Njenga MK. Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007. Am J Trop Med Hygiene. 2010;83(2 Suppl):22–7.
Njenga MK, Paweska J, Wanjala R, Rao CY, Weiner M, Omballa V, Luman ET, Mutonga D, Sharif S, Panning M. Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases. J Clin Microbiol. 2009;47(4):1166–71.
Article CAS PubMed PubMed Central Google Scholar
Anyangu AS, Gould LH, Sharif SK, Nguku PM, Omolo JO, Mutonga D, Rao CY, Lederman ER, Schnabel D, Paweska JT, Katz M, Hightower A, Njenga MK, Feikin DR, Breiman RF. Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hygiene. 2010;83(2 Suppl):14–21.
Smithburn K, Mahaffy A, Haddow A, Kitchen S, Smith J. Rift Valley fever: accidental infections among laboratory workers. J Immunol. 1949;62(2):213–27.
Article CAS PubMed Google Scholar
Ad SM, Harmon J, Nyakarahuka L, Balinandi S, Tumusiime A, Kyondo J, Mulei S, Namutebi A, Knust B, Shoemaker T, Nichol ST, McElroy AK, Spiropoulou CF. Rift Valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations. PLoS Negl Trop Dis 2018, 12(5).
Liu J, Sun Y, Shi W, Tan S, Pan Y, Cui S, Zhang Q, Dou X, Lv Y, Li X. The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages. Emerg Microbes Infections. 2017;6(1):1–7.
Bird BH, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST. Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry. J Virol. 2007;81(6):2805–16.
Article CAS PubMed Google Scholar
Nderitu L, Lee JS, Omolo J, Omulo S, O’Guinn ML, Hightower A, Mosha F, Mohamed M, Munyua P, Nganga Z. Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus. J Infect Dis. 2011;203(5):655–65.
Beasley D, Davis C, Whiteman M, Granwehr B, Kinney R, Barrett AD. Molecular determinants of virulence of West Nile virus in North America. Springer; 2004.
Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3(12):e201.
Article PubMed PubMed Central Google Scholar
Madani TA, Al-Mazrou YY, Al-Jeffri MH, Mishkhas AA, Al-Rabeah AM, Turkistani AM, Al-Sayed MO, Abodahish AA, Khan AS, Ksiazek TG. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis. 2003;37(8):1084–92.
Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious Mononucleosis in adolescents. Pediatrics. 2009;124(1):189–93.
Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomed Health Behav. 2020;8(2):61–9.
Lim E-J, Ahn Y-C, Jang E-S, Lee S-W, Lee S-H, Son C-G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Translational Med. 2020;18(1):1–15.
Lloyd AR. Fatigue after infection: aetiology and pathophysiology. Microbiol Australia. 2013;34(3):142–4.
Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, Chu L, Younger JW, Tato CM, Davis MM. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci. 2017;114(34):E7150–8.
Article CAS PubMed PubMed Central Google Scholar
Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 ‘long-haulers’? Chronic Dis Translational Med. 2021;7(1):14–26.
Hirche C, Frenz T, Haas SF, Döring M, Borst K, Tegtmeyer P-K, Brizic I, Jordan S, Keyser K, Chhatbar C. Systemic virus infections differentially modulate cell cycle state and functionality of long-term hematopoietic stem cells in vivo. Cell Rep. 2017;19(11):2345–56.
Article CAS PubMed Google Scholar
Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dörner T, Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006;6(10):741–50.
Article CAS PubMed Google Scholar
Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE. The pathogenesis of Rift Valley fever virus in the mouse model. Virology. 2010;407(2):256–67.
留言 (0)